Edwards Lifesciences

Life|Health

2 October 2025

Edwards Lifesciences Launches Groundbreaking Transcatheter Heart Valve Technology in Thailand

Edwards Lifesciences (NYSE: EW), the global leader in structural heart disease innovation, today announced the launch of its breakthrough next-generation transcatheter heart valve technology at the prestigious 26th-27th September Mahidol TAVI Symposium at Pullman Bangkok King Power. This launch aims to help alleviate Thailand’s escalating valvular heart disease burden—a key driver of cardiovascular deaths globally.…

Life|Health

10 June 2025

Edwards Lifesciences Launches Innovative Transcatheter Valve Repair System – A New Option for Treating Critically Ill Patients with Mitral Valve Regurgitation

In an era of continuous advancements in medical technology, Edwards Lifesciences (NYSE: EW), a global leader in patient-focused innovations for structural heart disease, has announced a significant breakthrough with the launch of its Transcatheter Mitral Valve Repair System in Thailand. This system provides a new treatment option for patients suffering from mitral regurgitation (MR), which…